Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (361) clinical trials

Meridien Research is conducting a six-month study to assess the effects of a new medication on individuals with relapsing forms of multiple sclerosis. If you are between 18 and 55 years of age, have up-to-date tetanus vaccinations and have been diagnosed with a relapsing form of multiple sclerosis, you may ...

Phase N/A

This is a 12-week study that will assess the safety and effectiveness of NUEDEXTA (Dextromethorphan 20mg/Quinidine10mg) in people who have Pseudobulbar Affect (PBA). PBA is a medical condition that causes sudden and involuntary bouts of crying or laughing in people with certain neurologic conditions or brain injuries. NUEDEXTA is currently ...

Phase N/A

The purpose of this study is to assess whether baclofen ER capsules demonstrate efficacy and safety in the treatment of spasticity.

Phase

Study Purpose: This is an observational study in men and women (patients >18 years old) who have been diagnosed with multiple sclerosis. The purpose of this study is to better characterize the long-term benefits and risks of dimethyl fumarate (DMF) medication in patients with multiple sclerosis (MS) who are prescribed ...

Phase

The purpose of this prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease-modifying therapy, is to further monitor the overall safety profile of fingolimod under conditions of routine medical practice and to explore the incidence of selected safety related outcomes. ...

Phase

The purpose of this prospective, parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease modifying therapy, is to further explore the incidence if selected safety and related outcomes and to further monitor the overall safety profile of fingolimod under conditions if ...

Phase

This is a randomized, 1:1, placebo-controlled, 10-week study of mirabegron as add-on therapy to an educational intervention on behavioral modification including pelvic floor exercise (BM-PFE) to a cohort of 40 Multiple Sclerosis (MS) subjects with overactive bladder (OAB). The trial will last approximately 12 weeks for each subject, including 4 ...

Phase

Peginterferon-beta-1a (PEG) is an approved treatment for relapsing forms of MS that may cause injection related erythema (skin redness). This is a randomized controlled cross-over trial of superficial hot and cold modalities to reduce injection site erythema caused by PEG. The most common adverse event associated with this subcutaneously (SC) ...

Phase N/A

This is an open-label, single-arm observational study to assess the impact of Tecfidera (dimethyl fumarate) on the gut microbiome following treatment initiation and determine whether a change in the microbiome correlates with the development of transient gastrointestinal disturbances and eosinophilia. This study will also address whether functional bowel syndrome as ...

Phase N/A